Eastern Cooperative Oncology Group

NCT07085728

Phase 2Recruiting202674 people25 Jul 2025clinicaltrials.gov

NCT06724237

Phase 3Recruiting2025294 people9 Dec 2024clinicaltrials.gov

NCT03488693

CollaboratorPhase 3Active, not recruiting20182,138 people5 Apr 2018clinicaltrials.gov

NCT00929591

CollaboratorPhase 3Completed19891,558 people29 Jun 2009clinicaltrials.gov

NCT00754845

CollaboratorPhase 3Completed20041,918 people18 Sept 2008clinicaltrials.gov

Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer

CollaboratorPhase 3Active, not recruiting20074,994 people12 Feb 2007clinicaltrials.gov

NCT00387699

Phase 2Completed200679 people13 Oct 2006clinicaltrials.gov

NCT00381706

CollaboratorPhase 2Completed2006245 people28 Sept 2006clinicaltrials.gov

NCT00335140

Phase 2Terminated200726 people8 Jun 2006clinicaltrials.gov

NCT00274924

Phase 2Completed2006100 people11 Jan 2006clinicaltrials.gov

NCT00217425

Phase 2Completed200646 people22 Sept 2005clinicaltrials.gov

NCT00127205

CollaboratorPhase 3Completed20056,097 people5 Aug 2005clinicaltrials.gov

NCT00113386

CollaboratorPhase 3Terminated200519 people8 Jun 2005clinicaltrials.gov

NCT00096174

Phase 2Completed200569 people9 Nov 2004clinicaltrials.gov

NCT00003172

Phase 2Completed19976 Sept 2004clinicaltrials.gov

NCT00002791

CollaboratorPhase 2Completed19972 Sept 2004clinicaltrials.gov

NCT00002631

CollaboratorPhase 3Completed1995298 people31 Aug 2004clinicaltrials.gov

NCT00003519

Phase 3Completed19982,778 people26 Aug 2004clinicaltrials.gov

NCT00003237

Phase 2Completed199855 people25 Aug 2004clinicaltrials.gov

NCT00002888

Phase 3Completed199724 Aug 2004clinicaltrials.gov